Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urologic Neoplasms × Pemetrexed × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 179 Lung Neoplasms 65 Neoplasms 22 Mesothelioma, Malignant 14 Adenocarcinoma of Lung 14 Neoplasm Metastasis 12 Mesothelioma 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Head and Neck Neoplasms 9 Carcinoma 9 Breast Neoplasms 8 Recurrence 5 Ovarian Neoplasms 5 Adenocarcinoma, Bronchiolo-Alveolar 5 Small Cell Lung Carcinoma 4 Colorectal Neoplasms 4 Adenocarcinoma 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Lung Diseases 3 Carcinoma, Small Cell 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Respiratory Tract Neoplasms 2 Osteosarcoma 2 Non-Squamous Non-Small Cell Lung Cancer 2

Interventions

Trastuzumab 2 valrubicin 1 niraparib 1 enfortumab vedotin 1 avelumab 1 Surveys and Questionnaires 1 Sunitinib 1 Sugammadex 1 Standard of Care 1 Paclitaxel 1 Neostigmine 1 Neoadjuvant Therapy 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Cetuximab 1 Afatinib 1 Administration, Intravesical 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡